Related Experiment Video
Updated: Aug 7, 2026

06:40
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
Modelling thrombin generation in human ovarian follicular fluid
Sharene D Bungay1, Patricia A Gentry, Rodney D Gentry
1Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1. sharene@cs.mun.ca
Bulletin of Mathematical Biology
|July 14, 2006
Summary
Thrombin production in ovarian follicular fluid is significantly lower than in blood plasma, insufficient for fibrin formation. This suggests thrombin in follicular fluid initiates cellular activities, not clotting.
Area of Science:
- Biochemistry
- Reproductive Biology
- Mathematical Modeling
Background:
- Thrombin plays a critical role in hemostasis and cellular signaling.
- Ovarian follicular fluid has unique biochemical properties distinct from blood plasma.
- The precise role and production of thrombin within the ovarian follicle remain incompletely understood.
Purpose of the Study:
- To mathematically model thrombin production in human ovarian follicular fluid.
- To compare thrombin generation potential in follicular fluid versus blood plasma.
- To elucidate the functional role of thrombin in the ovarian follicle.
Main Methods:
- Development of a mathematical model simulating thrombin production kinetics.
- Inclusion of key coagulation factors and inhibitors relevant to the follicular environment.
- Parametric analysis to assess the impact of reactant concentrations and pathway deficiencies.
Main Results:
- Modeled thrombin levels in follicular fluid are substantially lower than plasma levels, insufficient for fibrin formation.
- The absence of the amplification pathway in follicular fluid significantly limits thrombin production.
- Tissue factor and phospholipid concentrations are critical for sustaining thrombin production.
Conclusions:
- Thrombin in follicular fluid likely functions in initiating cellular activities via signaling receptors rather than coagulation.
- The limited thrombin generation capacity is attributed to the lack of an amplification pathway.
- Further experimental validation is required to determine crucial parameter values for factors like Factor V and thrombomodulin.
